3 Fantastic Biotech Stocks to Buy in April
There are always exceptions. Keep that in mind when considering the overall dismal performance of biotech stocks over the past year. A few outliers are continuing to swim against the tide and remain solid picks for investors.
We asked three Motley Fool contributors to identify fantastic biotech stocks to buy in April. Here's why they chose Novartis (NYSE: NVS), Regeneron Pharmaceuticals (NASDAQ: REGN), and Vertex Pharmaceuticals (NASDAQ: VRTX).
Source Fool.com